NewEdge Advisors’s Aehr Test Systems AEHR Stock Holding History

NewEdge Advisors’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Sell	3,761 -8,321	-69%	-$760K	﹤0.01%	2347
2026 Q1	$448K	Sell	12,082 -722	-6%	-$23.1K	﹤0.01%	2085
2025 Q4	$259K	Sell	12,804 -3,155	-20%	-$76.3K	﹤0.01%	2415
2025 Q3	$481K	Buy	15,959 +15,914	+35,364%	+$345K	﹤0.01%	1846
2025 Q2	$582	Hold	45	–	–	﹤0.01%	3786
2025 Q1	$328	Sell	45 -100	-69%	-$1.11K	﹤0.01%	3761
2024 Q4	$2.41K	Hold	145	–	–	﹤0.01%	3413
2024 Q3	$1.86K	Sell	145 -540	-79%	-$7.81K	﹤0.01%	3395
2024 Q2	$7.65K	Sell	685 -400	-37%	-$4.66K	﹤0.01%	2950
2024 Q1	$13.5K	Sell	1,085 -19,482	-95%	-$325K	﹤0.01%	2770
2023 Q4	$546K	Buy	20,567 +5,957	+41%	+$174K	0.01%	1237
2023 Q3	$668K	Buy	14,610 +9,225	+171%	+$428K	0.01%	1049
2023 Q2	$222K	Buy	5,385 +1,455	+37%	+$47.7K	﹤0.01%	1591
2023 Q1	$122K	Sell	3,930 -3,908	-50%	-$126K	﹤0.01%	1689
2022 Q4	$8.09K	Buy	+7,838	New	+$168K	﹤0.01%	2437

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NewEdge Advisors's AEHR Position: Q2 2026 in Review

NewEdge Advisors reduced its Aehr Test Systems (AEHR) stake by 69% in Q2 2026, selling an estimated $760K and leaving 3,761 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

NewEdge Advisors first reported a position in AEHR in Q4 2022 and has held it in 15 quarters since. The position peaked at $668K in Q3 2023. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

NewEdge Advisors held 3,761 shares of Aehr Test Systems worth $361K as of Q2 2026.
NewEdge Advisors sold 8,321 Aehr Test Systems shares in Q2 2026, an estimated $760K.
Aehr Test Systems made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2347 holding.
NewEdge Advisors first reported a position in Aehr Test Systems in Q4 2022 and has held it in 15 quarters since.
NewEdge Advisors's Aehr Test Systems position peaked at $668K in Q3 2023.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.